Your browser doesn't support javascript.
loading
Application of CRISPR/Cas9 in tumor immunotherapy / 中国免疫学杂志
Chinese Journal of Immunology ; (12): 122-126, 2018.
Artigo em Chinês | WPRIM | ID: wpr-702686
ABSTRACT
In recent years,tumor immunotherapy has attracted more and more attention because of its remarkable curative effect and innovation.With the development of CRISPR gene editing system and its application in many fields,researchers have seen its great potential,especially in the field of cancer research.For adoptive cell therapy,CRISPR/Cas9 can knockout endogenous TCR and HLA-Ⅰ genes in TCR-T and CAR-T cells to generate universal effective T cells.It provided a new method to inhibit and block the immune checkpoint.The application of CRISPR/Cas9 in genetic screening makes antibody targeted therapy to a new level.CRISPR has greatly promoted the research of tumor immunotherapy.This article introduced the application of CRISPR/Cas9 gene editing system in tumor immunotherapy.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Immunology Ano de publicação: 2018 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Immunology Ano de publicação: 2018 Tipo de documento: Artigo